← Back to Services
Service
Financial Modeling & Valuation
Analytical rigor at the core of every engagement.
Precision valuation and financial modeling for biotechnology, life sciences, and medical device companies. Includes DCF, risk-adjusted NPV, comparable transactions, licensing economics, and capital allocation analysis.
Financial modeling and valuation serve as the analytical foundation across all engagement types—from pricing an equity round to structuring a licensing deal or prioritizing pipeline programs.